Dosing time and sex-related differences in the pharmacokinetics of cefodizime and in the circadian cortisol rhythm. 1988

J H Jonkman, and A Reinberg, and B Oosterhuis, and O E de Noord, and F A Kerkhof, and Y Motohashi, and F Levi, and F Dammacco, and F Carandente
Pharma Bio-Research International Institute for Clinical Pharmacology, Assen, The Netherlands.

Two g cefodizime i.v. administration at 00:00, 06:00, 12:00 and 18:00 respectively, to 8 male and 8 female, young healthy volunteers, has shown: 1. a sex-related difference in both plasma (AUC) and total cumulative excretion of the agent with larger values in females than in males; 2. a dosing time-related difference in plasma (AUC) with the largest values for Rx at 00:00 and lowest for Rx at 18:00 in both males and females; 3. a dosing time-related difference in urinary concentration of cefodizime with largest values for Rx at 06:00 and lowest for Rx at 12:00. These urinary changes were highly correlated with changes in AUC for each dosing time; 4. no dosing time-related changes were observed for plasma T1/2 as well as cumulative urinary excretion of cefodizime; 5. curve patterns of plasma cortisol had similar aspects for both control and Rx at 00:00 with no sex-related differences. Curve patterns differed from control for other dosing times (p less than 0.005 to p less than 0.001 with ANOVA tests).

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D002439 Cefotaxime Semisynthetic broad-spectrum cephalosporin. Benaxima,Biosint,Cefotaxim,Cefotaxime Sodium,Cefradil,Cephotaxim,Claforan,Fotexina,HR-756,Kendrick,Klaforan,Primafen,Ru-24756,Taporin,HR 756,HR756,Ru 24756,Ru24756,Sodium, Cefotaxime
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012737 Sex Factors Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances. Factor, Sex,Factors, Sex,Sex Factor

Related Publications

J H Jonkman, and A Reinberg, and B Oosterhuis, and O E de Noord, and F A Kerkhof, and Y Motohashi, and F Levi, and F Dammacco, and F Carandente
June 1976, Horumon to rinsho. Clinical endocrinology,
J H Jonkman, and A Reinberg, and B Oosterhuis, and O E de Noord, and F A Kerkhof, and Y Motohashi, and F Levi, and F Dammacco, and F Carandente
June 1979, Nihon rinsho. Japanese journal of clinical medicine,
J H Jonkman, and A Reinberg, and B Oosterhuis, and O E de Noord, and F A Kerkhof, and Y Motohashi, and F Levi, and F Dammacco, and F Carandente
May 2011, Chronobiology international,
J H Jonkman, and A Reinberg, and B Oosterhuis, and O E de Noord, and F A Kerkhof, and Y Motohashi, and F Levi, and F Dammacco, and F Carandente
September 1985, The Journal of clinical endocrinology and metabolism,
J H Jonkman, and A Reinberg, and B Oosterhuis, and O E de Noord, and F A Kerkhof, and Y Motohashi, and F Levi, and F Dammacco, and F Carandente
January 1989, European journal of clinical pharmacology,
J H Jonkman, and A Reinberg, and B Oosterhuis, and O E de Noord, and F A Kerkhof, and Y Motohashi, and F Levi, and F Dammacco, and F Carandente
March 2024, Medicina (Kaunas, Lithuania),
J H Jonkman, and A Reinberg, and B Oosterhuis, and O E de Noord, and F A Kerkhof, and Y Motohashi, and F Levi, and F Dammacco, and F Carandente
June 2010, Chemico-biological interactions,
J H Jonkman, and A Reinberg, and B Oosterhuis, and O E de Noord, and F A Kerkhof, and Y Motohashi, and F Levi, and F Dammacco, and F Carandente
September 1983, Bollettino della Societa italiana di biologia sperimentale,
J H Jonkman, and A Reinberg, and B Oosterhuis, and O E de Noord, and F A Kerkhof, and Y Motohashi, and F Levi, and F Dammacco, and F Carandente
December 1982, Pathologie-biologie,
J H Jonkman, and A Reinberg, and B Oosterhuis, and O E de Noord, and F A Kerkhof, and Y Motohashi, and F Levi, and F Dammacco, and F Carandente
August 2003, Early human development,
Copied contents to your clipboard!